Bioorganic and Medicinal Chemistry Letters p. 2151 - 2156 (1999)
Update date:2022-08-05
Topics:
Hu, Lain-Yen
Ryder, Todd R.
Rafferty, Michael F.
Dooley, David J.
Geer, Joann J.
Lotarski, Susan M.
Miljanich, George P.
Millerman, Elizabeth
Rock, David M.
Stoehr, Sally J.
Szoke, Balazs G.
Taylor, Charles P.
Vartanian, Mark G.
Selective N-type voltage sensitive calcium channel (VSCC) blockers have shown efficacy in several animal models of stroke and pain. In the process of searching for small molecule N-type calcium channel blockers, we have identified a series of N-methyl-N-aralkyl-peptidylamines with potent functional activity at N-type VSCCs. The most active compound discovered in this series is PD 173212 (11, IC50 = 36 nM in the IMR32 assays). SAR and pharmacological evaluation of this series are described.
View MoreChangyi Xinxing Technology Development Co., Ltd.
Contact:0086-510-86651065(Time Zone:8),86651656
Address:94 Yingbinxilu WestRoad, Huangtu Town, Jiangyin City, Jiangsu, China
Jewim Pharmaceutical (Shandong) Co., Ltd
Contact:+8615621883869
Address:山东省泰安市高新技术产业开发区配天门大街西首
Contact:+65 9658 0999
Address:26 Sin Ming Lane, Midview City, #05-118, Singapore 573971
Shandong Xingshun New Material Co., Ltd.
website:http://www.sd-xingshun.com
Contact:+86-519-86461196
Address:Middle of Luhua East Road, Dingtao District
Contact:+86-021-6989-5597
Address:No.80 Yichuan Rd., Putuo District,Shanghai,P.R.China
Doi:10.1002/anie.201005212
(2011)Doi:10.1016/S0040-4039(01)80728-0
(1989)Doi:10.1021/jo102228j
(2011)Doi:10.1016/j.ejmech.2010.11.001
(2011)Doi:10.1016/S0040-4039(01)80781-4
(1989)Doi:10.1134/S1070363210110277
(2010)
